Ling Wang

5.0k total citations · 1 hit paper
120 papers, 3.7k citations indexed

About

Ling Wang is a scholar working on Molecular Biology, Pharmacology and Computational Theory and Mathematics. According to data from OpenAlex, Ling Wang has authored 120 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Molecular Biology, 31 papers in Pharmacology and 23 papers in Computational Theory and Mathematics. Recurrent topics in Ling Wang's work include Computational Drug Discovery Methods (23 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Ling Wang is often cited by papers focused on Computational Drug Discovery Methods (23 papers), PI3K/AKT/mTOR signaling in cancer (14 papers) and Chronic Lymphocytic Leukemia Research (7 papers). Ling Wang collaborates with scholars based in China, United States and Norway. Ling Wang's co-authors include Robin Farias‐Eisner, Srinivasa T. Reddy, John A. Glaspy, Dilprit Bagga, Duancheng Zhao, Yanbin Cai, Shuangshuang He, Jie Zhan, Zhimou Yang and Ying Yan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Angewandte Chemie International Edition.

In The Last Decade

Ling Wang

112 papers receiving 3.6k citations

Hit Papers

Differential effects of p... 2003 2026 2010 2018 2003 100 200 300 400 500

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Ling Wang 1.5k 567 536 444 405 120 3.7k
Gholamreza Dehghan 1.9k 1.3× 388 0.7× 732 1.4× 145 0.3× 193 0.5× 217 5.0k
Yuanyuan Xie 897 0.6× 545 1.0× 496 0.9× 169 0.4× 173 0.4× 167 3.7k
Dongfeng Chen 3.3k 2.1× 633 1.1× 147 0.3× 147 0.3× 246 0.6× 266 7.1k
Dandan Wang 1.9k 1.2× 333 0.6× 289 0.5× 123 0.3× 222 0.5× 205 4.4k
Wenyuan Liu 2.2k 1.4× 1.1k 1.9× 1.0k 1.9× 437 1.0× 102 0.3× 319 5.8k
Xue Qiao 4.2k 2.7× 1.1k 1.9× 201 0.4× 128 0.3× 238 0.6× 222 6.7k
Tian Xie 3.4k 2.2× 401 0.7× 312 0.6× 152 0.3× 99 0.2× 211 6.2k
Song Ja Kim 1.7k 1.1× 555 1.0× 365 0.7× 83 0.2× 176 0.4× 157 4.1k
Min Liu 1.3k 0.8× 193 0.3× 589 1.1× 89 0.2× 187 0.5× 234 3.9k

Countries citing papers authored by Ling Wang

Since Specialization
Citations

This map shows the geographic impact of Ling Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ling Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ling Wang more than expected).

Fields of papers citing papers by Ling Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ling Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ling Wang. The network helps show where Ling Wang may publish in the future.

Co-authorship network of co-authors of Ling Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ling Wang. A scholar is included among the top collaborators of Ling Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ling Wang. Ling Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Lingyu, Wansong Lin, Zhifeng Zhou, et al.. (2025). Synergistic blockade of SHP-2 and A2AR signal pathways with targeted nanoparticles restores anti-tumor immunity of CD8+ T cells. Journal of Controlled Release. 384. 113889–113889.
3.
Wang, Ling, et al.. (2024). Identification of predictive markers of Pneumocystis jirovecii pneumonia in kidney transplant recipients. Transplant Immunology. 85. 102074–102074.
4.
Sun, Yu, et al.. (2024). Rigid-Soft Hybrid Suction Cups for Enhanced Anti-Torque and Energy-Efficient Attachment. IEEE Robotics and Automation Letters. 9(12). 10970–10977.
5.
Sun, Qiwen, Nana Zhang, Rui Chen, et al.. (2024). Design, Synthesis, Formulation, and Bioevaluation of Trisubstituted Triazines as Highly Selective mTOR Inhibitors for the Treatment of Human Breast Cancer. Journal of Medicinal Chemistry. 67(9). 7330–7358. 8 indexed citations
6.
Yang, Rui, Shibo Sun, Haowen Liu, et al.. (2024). Pharmacological Inhibition of TXNRD1 by a Small Molecule Flavonoid Butein Overcomes Cisplatin Resistance in Lung Cancer Cells. Biological Trace Element Research. 203(4). 1949–1960. 4 indexed citations
7.
Chen, Yi‐Hao, et al.. (2024). MalariaFlow: A comprehensive deep learning platform for multistage phenotypic antimalarial drug discovery. European Journal of Medicinal Chemistry. 277. 116776–116776. 7 indexed citations
9.
Zhao, Shanshan, et al.. (2023). Identifying novel selective PPO inhibitors through structure-based virtual screening and bio-evaluation. RSC Advances. 13(16). 10873–10883. 4 indexed citations
10.
Wang, Ling, et al.. (2023). In-vitro evaluation of immunomodulatory activity of sulphation-modified total ginsenosides derivative-3. Frontiers in Veterinary Science. 10. 1068315–1068315. 1 indexed citations
11.
Wang, Ling, et al.. (2023). Dual targeting of Mcl-1 and Bcl-2 to overcome chemoresistance in cervical and colon cancer. Anti-Cancer Drugs. 35(3). 219–226. 4 indexed citations
12.
Yue, Yang, Lijie Wu, Yiran Wu, et al.. (2022). Structural insight into apelin receptor-G protein stoichiometry. Nature Structural & Molecular Biology. 29(7). 688–697. 42 indexed citations
13.
Yue, Jieyu, et al.. (2021). Novel enzyme-functionalized covalent organic frameworks for the colorimetric sensing of glucose in body fluids and drinks. Materials Chemistry Frontiers. 5(10). 3859–3866. 48 indexed citations
14.
Wang, Ling, Thomas J. Matthew, Avneesh K. Saini, et al.. (2021). Multimeric Anti-DR5 IgM Agonist Antibody IGM-8444 Is a Potent Inducer of Cancer Cell Apoptosis and Synergizes with Chemotherapy and BCL-2 Inhibitor ABT-199. Molecular Cancer Therapeutics. 20(12). 2483–2494. 30 indexed citations
15.
Wang, Qingchen, Rui Chen, Hailing Zhou, et al.. (2021). Synthesis and bioevaluation of diaryl urea derivatives as potential antitumor agents for the treatment of human colorectal cancer. European Journal of Medicinal Chemistry. 229. 114055–114055. 25 indexed citations
16.
Yin, Haoyong, Junli Chen, Ling Wang, et al.. (2020). Polyhedral NiO/C porous composites derived by controlled pyrolysis of Ni-MOF for highly efficient non-enzymatic glucose detection. Journal of Materials Science Materials in Electronics. 31(5). 4323–4335. 23 indexed citations
17.
Yu, Jianhua, et al.. (2018). PI3K‐PKB‐mTOR hyperactivation in relation to nasopharyngeal carcinoma progression and prognosis. Journal of Cellular Biochemistry. 120(6). 10186–10194. 10 indexed citations
18.
Liu, Yan, Xiaojie Tan, Wenbin Liu, et al.. (2018). Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma. Chinese Journal of Cancer. 37(1). 2–2. 21 indexed citations
20.
Wang, Xu, et al.. (2009). Presence and regulation of cannabinoid receptors in human retinal pigment epithelial cells.. PubMed. 15. 1243–51. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026